Development of an Orally Bioavailable CDK12/13 Degrader and Induction of Synthetic Lethality with AKT Pathway Inhibition
CELL REPORTS(2024)
Key words
CDK12,CDK13,AKT,proteolysis targeting chimera,PROTAC,synthetic lethality,prostate cancer,AKT inhibitors
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined